Bayer shareholders vented their anger over its stock price slump on Friday as litigation risks mount from the German drugmaker's $63 billion takeover of seed maker Monsanto.

from Reuters: Business News https://reut.rs/2IIKJ5E
via IFTTT
from Reuters: Business News https://reut.rs/2IIKJ5E
via IFTTT
Post a Comment